Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Hold
8,108
0.02% 266
2026
Q1
$447K Sell
8,108
-20
-0.2% -$1.08K 0.02% 258
2025
Q4
$399K Buy
+8,128
New +$379K 0.02% 259

Other funds holding GSK

North Star Asset Management's GSK Position: Q2 2026 in Review

North Star Asset Management held its GSK (GSK) position steady in Q2 2026 at 8,108 shares worth $425K. The position accounts for 0.02% of the portfolio, ranked #266.

North Star Asset Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $447K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • North Star Asset Management held 8,108 shares of GSK worth $425K as of Q2 2026.
  • North Star Asset Management left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.02% of North Star Asset Management's portfolio in Q2 2026, its #266 holding.
  • North Star Asset Management first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • North Star Asset Management's GSK position peaked at $447K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.